An analysis of the use of a point-of-care system for international normalized ratio testing in remote areas of Canada: A literature review

Point of Care

Volumn 7, Issue 1, 2008, Pages 34-37

  James, Manuel ^a,b  

^a Annie Bagg Memorial Nursing Station   (Canada)

^b NONE   (Canada)

Author keywords

Anticoagulation; Economic analysis; Point of Care testing; Time in therapeutic range

Indexed keywords

EID: 41849142981     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e318162f369     Document Type: Review

References (18)

1. Health Canada. The HC disease and condition page. Available at: http://www.hc-sc.gc.ca/dc-ma/heart-coeur/index_e.html. Accessed March 1, 2007.
2. Ansell JE, Oertel LB, Wittkowsky AK. Managing Oral Anticoagulation Therapy. 2nd ed. St Louis, MO: Facts & Comparisons; 2003.
3. Melanson SEF. What's new in Point-of-Care testing in 2005? Point Care. 2006;5:74-76.
4. Shephard M, Mazzachi BC, Shephard AK, et al. Point-of-Care testing in aboriginal hands - a model for chronic disease prevention and management in indigenous Australia. Point Care. 2006;5(4):168-176.
5. Murray ET, Greaves M. INRs and point of care testing. BMJ. 2003;327:5-6. Available at: http://www.bmj.com. Accessed October 8, 2006.
6. Andrew M, Ansell J, Becker D, et al. Multicenter trial of accurate home self-testing in oral anticoagulant patients with a novel whole blood system. Blood. 1996;88:179a.
7. White RH, McCurdy SA, von Marensdorff H, et al. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med. 1989;111:730-737.
8. Jackson SL, Bereznicki R, Peterson GM, et al. Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic. Clin Lab Haematol. 2004;26:49-55.
9. Gardiner C, Williams K, Mackie IJ, et al. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol. 2004;128:242-247.
10. McBane RD II, Felty CL, Hartgers ML, et al. Importance of device evaluation for Point-of-Care prothrombine time international normalized ratio testing program. Mayo Clin Proc. 2005;80(2):181-186. Available at: http://www.mayoclinicproceedings.com. Accessed October 8, 2006.
11. Dorfman DM, Goonan EM, Boutilier MK, et al. Point-of-Care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation. Vasc Med. 2005;10:23-27.
12. Regier DA, Sunderji R, Lynd LD, et al. Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. CMAJ. 2006;174:1847-1852.
13. Price CP. Point of care testing. BMJ. 2001;322:1285-1288. Available at: http://www.bmj.com. Accessed October 8, 2006.
14. Yang DT, Robetorye RS, Rodgers GM. Home prothrombin time monitoring: a literature analysis. Am J Hematol. 2004;77:177-186.
15. Taborski U, Wittsmann FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Hemost. 1999;25:103-107.
16. Cheung DS, Heizer D, Wilson J, et al. Cost-savings analysis of using a portable coagulometer for monitoring homebound elderly patients taking warfarin. Am J Geriatr Cardiol. 2003;12(5):283-287.
17. Boone DJ, Hay JW, Aguanno J, et al. Are the correct economic factors influencing Point-of-Care testing? Point Care. 2002;1(3):212-221.
18. Parry P, Fitzmaurice D, Raftery J. Anticoagulation management in primary care: a trial-based economic evaluation. Br J Haematol. 2000;111:530-533.